Cerebrovasular imaging company iSchemaView has received the FDA nod for its latest product the RAPID CTA, a 3D imaging platform for computed tomogrpahy angiography (CTA).
from MobiHealthNews https://ift.tt/2KxeZOk
May 03, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Digital health news briefs for 1/3/2018NHS set to offer AI system free to all hospitals. The BBC is reporting that new AI systems for interpreting cardiac and lung scans could save England's National Health Service a billion pounds. The cardiac system, called Ultr… Read More
Startup Health lands $19.3 million in funds to help startupsStartUp Health, a digital health group that supports, connects and finances startups, just landed $19.3 million from Ping An Global Voyager Fund, GuideWell, Masimo Corporation, and a consortium of partners through its Transfo… Read More
NYT, Bloomberg say Apple is working on Watch EKG, noninvasive glucoseCiting anonymous sources within Apple, reports in Bloomberg and the New York Times over the past weeks continue to add to the pile of leaks and rumors about two of Apple's currently under-developme from MobiHealthNews http:/… Read More
Canada will use AI to monitor suicidal social media postsThis year the Canadian government will start using artificial intelligence to help track social media posts that could indicate someone is at risk of suicide, according to a contract. from MobiHealthNews http://ift.tt/… Read More
Pear Therapeutics rakes in $50M to develop additional digital therapeuticsBoston- and San Francisco-based Pear Therapeutics, maker of a prescription digital therapeutic platform, announced today the closure of $50 million in Series B funding. The round was led by Singapore-based investment company … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment